Brain magnetic resonance imaging in the DE50-MD dog model of Duchenne muscular dystrophy reveals regional reductions in cerebral gray matter
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background: Duchenne muscular dystrophy is a X-linked disease characterized by severe and progressive muscle weakness, alongside cognitive impairment and a range of neurobehavioral disorders secondary to brain dystrophin deficiency. Duchenne muscular dystrophy patients have reduced cerebral gray matter and altered white matter ultrastructure (detected by magnetic resonance imaging) compared to age-matched controls. Methods: We studied the DE50-MD canine model of Duchenne muscular dystrophy, which is deficient in full length brain dystrophin (Dp427) isoforms and has a neurocognitive phenotype. Eight DE50-MD and 6 age-matched littermate wild type male dogs underwent serial brain magnetic resonance imaging from 14 to 33 months of age. Results: Reduced regional gray matter was detected in DE50-MD dogs compared with wildtype, including the piriform lobe, hippocampus and cingulate gyrus. Lateral ventricle volume was larger in DE50-MD dogs. Differences did not progress over time. White matter volume did not differ between DE50-MD and wildtype dogs. There was no difference in brain nor cranial vault volume between DE50-MD and wildtype dogs. Conclusion: Dystrophin deficiency in the canine brain results in structural changes that likely contribute to the neurocognitive phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“as well as regional reductions in grey matter and increased ventricular volume (Crawford et al., 2023).”
From Understanding Duchenne muscular dystrophy-associated brain pathology (2025) · cites this paper as Crawford et al., 2023
In the citing paper
“Studies on the canine brain are limited to the DE50-MD dog (which has a missense mutation in the donor splice site of exon 50 and consequently lacks only Dp427), which have reported reduced attention, problem solving and exploration of novel objects (Crawford et al., 2022), as well as regional reductions in grey matter and increased ventricular volume (Crawford et al., 2023).”
From Understanding Duchenne muscular dystrophy-associated brain pathology (2025) · cites this paper as Crawford et al., 2023
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vaillend, C., Billard, J.-M., & Laroche, S. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.05.004 · Cited by 169
Vaillend, C., Rendon, A., Misslin, R., & Ungerer, A. (1995) · Behavior Genetics · doi:10.1007/bf02327580 · Cited by 112
Research works printed but not linked: 37
- Cotton S, Voudouris NJ, Greenwood KM. Intelligence and Duchenne muscular dystrophy: full-scale, verbal, and performance intelligence quotients. Dev Med Child Neurol. 2001;43(7):497–501. · DOI · Paper page
- Banihani R, Smile S, Yoon G, Dupuis A, Mosleh M, Snider A, et al. Cognitive and neurobehavioral profile in boys with duchenne muscular dystrophy. J Child Neurol. 2015;30(11):1472–82. · DOI · Paper page
- Hendriksen JG, Vles JS. Neuropsychiatric disorders in males with duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive–compulsive disorder. J Child Neurol. 2008;23(5):477–81. · DOI · Paper page
- Pane M, Messina S, Bruno C, D’Amico A, Villanova M, Brancalion B, et al. Duchenne muscular dystrophy and epilepsy. Neuromuscular Disord NMD. 2013;23(4):313–5. · DOI · Paper page
- Doorenweerd N, Mahfouz A, van Putten M, Kaliyaperumal R, PAC TH, Hendriksen JGM, et al. Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy. Sci Rep. 2017;7(1):12575. · DOI · Paper page
- Bulfield G, Siller WG, Wight PA, Moore KJ. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA. 1984;81(4):1189–92. · DOI · Paper page
- Larcher T, Lafoux A, Tesson L, Remy S, Thepenier V, Francois V, et al. Characterization of dystrophin deficient rats: a new model for Duchenne muscular dystrophy. PLoS ONE. 2014;9(10): e110371. · DOI · Paper page
- Walmsley GL, Arechavala-Gomeza V, Fernandez-Fuente M, Burke MM, Nagel N, Holder A, et al. A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping. PLoS ONE. 2010;5(1): e8647. · DOI
- Kornegay JN. The golden retriever model of Duchenne muscular dystrophy. Skelet Muscle. 2017;7(1):9. · DOI · Paper page
- Klymiuk N, Blutke A, Graf A, Krause S, Burkhardt K, Wuensch A, et al. Dystrophin-deficient pigs provide new insights into the hierarchy of physiological derangements of dystrophic muscle. Hum Mol Genet. 2013;22(21):4368–82. · DOI · Paper page
- McGreevy JW, Hakim CH, McIntosh MA, Duan D. Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy. Dis Model Mech. 2015;8(3):195–213. · DOI · Paper page
- Crawford AH, Hildyard JCW, Rushing SAM, Wells DJ, Diez-Leon M, Piercy RJ. Validation of DE50-MD dogs as a model for the brain phenotype of Duchenne muscular dystrophy. Dis Model Mech. 2022;15(3):dmm049291. · DOI · Paper page
- Kogelman B, Khmelinskii A, Verhaart I, Vliet LV, Bink DI, Aartsma-Rus A, et al. Influence of full-length dystrophin on brain volumes in mouse models of Duchenne muscular dystrophy. PLoS ONE. 2018;13(3): e0194636. · DOI
- Saoudi A, Zarrouki F, Sebrie C, Izabelle C, Goyenvalle A, Vaillend C. Emotional behavior and brain anatomy of the mdx52 mouse model of Duchenne muscular dystrophy. Dis Model Mech. 2021;14(9):dmm040028. · DOI · Paper page
- Doorenweerd N, Dumas EM, Ghariq E, Schmid S, Straathof CS, Roest AA, et al. Decreased cerebral perfusion in duchenne muscular dystrophy patients. Neuromuscular Disord NMD. 2017;27(1):29–37. · DOI
- Doorenweerd N, Straathof CS, Dumas EM, Spitali P, Ginjaar IB, Wokke BH, et al. Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophy. Ann Neurol. 2014;76(3):403–11. · DOI · Paper page
- Preethish-Kumar V, Shah A, Kumar M, Ingalhalikar M, Polavarapu K, Afsar M, et al. In Vivo evaluation of white matter abnormalities in children with duchenne muscular dystrophy using DTI. AJNR Am J Neuroradiol. 2020;41(7):1271–8. · DOI · Paper page
- Snow WM, Anderson JE, Jakobson LS. Neuropsychological and neurobehavioral functioning in Duchenne muscular dystrophy: a review. Neurosci Biobehav Rev. 2013;37(5):743–52. · DOI · Paper page
- Muntoni F, Mateddu A, Serra G. Passive avoidance behaviour deficit in the mdx mouse. Neuromuscular Disord NMD. 1991;1(2):121–3. · DOI · Paper page
- Sekiguchi M, Zushida K, Yoshida M, Maekawa M, Kamichi S, Yoshida M, et al. A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice. Brain J Neurol. 2009;132(Pt 1):124–35. · DOI · Paper page
- Remmelink E, Aartsma-Rus A, Smit AB, Verhage M, Loos M, van Putten M. Cognitive flexibility deficits in a mouse model for the absence of full-length dystrophin. Genes Brain Behav. 2016;15(6):558–67. · DOI · Paper page
- Miranda R, Sebrie C, Degrouard J, Gillet B, Jaillard D, Laroche S, et al. Reorganization of inhibitory synapses and increased PSD length of perforated excitatory synapses in hippocampal area CA1 of dystrophin-deficient mdx mice. Cereb Cortex. 2009;19(4):876–88. · DOI · Paper page
- Xu S, Shi D, Pratt SJP, Zhu W, Marshall A, Lovering RM. Abnormalities in brain structure and biochemistry associated with mdx mice measured by in vivo MRI and high resolution localized (1)H MRS. Neuromuscular Disord NMD. 2015;25(10):764–72. · DOI · Paper page
- Lv SY, Zou QH, Cui JL, Zhao N, Hu J, Long XY, et al. Decreased gray matter concentration and local synchronization of spontaneous activity in the motor cortex in Duchenne muscular dystrophy. AJNR Am J Neuroradiol. 2011;32(11):2196–200. · DOI · Paper page
- Doorenweerd N, de Rover M, Marini-Bettolo C, Hollingsworth KG, Niks EH, Hendriksen JGM, et al. Resting-state functional MRI shows altered default-mode network functional connectivity in Duchenne muscular dystrophy patients. Brain Imaging Behav. 2021;15(5):2297–307. · DOI · Paper page
- Lee JS, Pfund Z, Juhasz C, Behen ME, Muzik O, Chugani DC, et al. Altered regional brain glucose metabolism in duchenne muscular dystrophy: a pet study. Muscle Nerve. 2002;26(4):506–12. · DOI · Paper page
- Vaillend C, Chaussenot R. Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice. Hum Mol Genet. 2017;26(6):1041–55.
- Fritschy JM, Panzanelli P, Tyagarajan SK. Molecular and functional heterogeneity of GABAergic synapses. Cell Mol Life Sci CMLS. 2012;69(15):2485–99. · DOI
- Perronnet C, Vaillend C. Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies. J Biomed Biotechnol. 2010;2010: 849426.
- Darmahkasih AJ, Rybalsky I, Tian C, Shellenbarger KC, Horn PS, Lambert JT, et al. Neurodevelopmental, behavioral, and emotional symptoms common in Duchenne muscular dystrophy. Muscle Nerve. 2020;61(4):466–74. · DOI · Paper page
- Pangalila RF, van den Bos GA, Bartels B, Bergen M, Stam HJ, Roebroeck ME. Prevalence of fatigue, pain, and affective disorders in adults with duchenne muscular dystrophy and their associations with quality of life. Arch Phys Med Rehabil. 2015;96(7):1242–7. · DOI
- Trimmer RMK, Mandy F. Understanding anxiety experienced by boys with Duchenne muscular dystrophy: a qualitative focus group study british paediatric neurology association annual Meeting Belfast. Hoboken: Blackwell Publishing Ltd; 2020.
- Maresh K, Papageorgiou A, Ridout D, Harrison NA, Mandy W, Skuse D, et al. Startle responses in duchenne muscular dystrophy: a novel biomarker of brain dystrophin deficiency brain. J Neurol. 2022;146(1):252.
- Conboy V, Edwards C, Ainsworth R, Natusch D, Burcham C, Danisment B, et al. Chronic musculoskeletal impairment is associated with alterations in brain regions responsible for the production and perception of movement. J Physiol. 2021;599(8):2255–72. · DOI
- Liepert J, Tegenthoff M, Malin JP. Changes of cortical motor area size during immobilization. Electroencephalogr Clin Neurophysiol. 1995;97(6):382–6. · DOI · Paper page
- Brown ES, Woolston DJ, Frol AB. Amygdala volume in patients receiving chronic corticosteroid therapy. Biol Psychiatry. 2008;63(7):705–9. · DOI
- Coburn-Litvak PS, Tata DA, Gorby HE, McCloskey DP, Richardson G, Anderson BJ. Chronic corticosterone affects brain weight, and mitochondrial, but not glial volume fraction in hippocampal area CA3. Neuroscience. 2004;124(2):429–38. · DOI
Cited by
Understanding Duchenne muscular dystrophy-associated brain pathology
Verhaeg, M. A. T., Govaarts, R., & van Putten, M. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052302 · Cited by 5
Metadata
- Authors
- Crawford, A. H., Hornby, N. L., de la Fuente, A. G., & Piercy, R. J.
- Venue
- BMC Neuroscience
- Published
- 2023-03-17
- Volume
- 24
- Issue
- 1
- ISSN
- 1471-2202
- Cited by
- 7
- References
- 2
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Funders
- Academy of Medical Sciences (SGL020\1081)
- Wellcome Trust (CP21/00032, 101550/Z/13/Z)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Brain magnetic resonance imaging in the DE50-MD dog model of Duchenne muscular dystrophy reveals regional reductions in cerebral gray matter. https://app.cochat.ai/papers/10.1186/s12868-023-00788-2
- The paper
- Crawford, A. H., Hornby, N. L., de la Fuente, A. G., & Piercy, R. J. (2023). Brain magnetic resonance imaging in the DE50-MD dog model of Duchenne muscular dystrophy reveals regional reductions in cerebral gray matter. BMC Neuroscience. https://doi.org/10.1186/s12868-023-00788-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.